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a b s t r a c t
Cocaine accelerates human immunodeﬁciency virus (HIV-1) replication by altering speciﬁc cell-signaling
and epigenetic pathways. We have elucidated the underlying molecular mechanisms through which
cocaine exerts its effect in myeloid cells, a major target of HIV-1 in central nervous system (CNS). We
demonstrate that cocaine treatment promotes HIV-1 gene expression by activating both nuclear factor-
kappa B (NF-ĸB) and mitogen- and stress-activated kinase 1 (MSK1). MSK1 subsequently catalyzes the
phosphorylation of histone H3 at serine 10, and p65 subunit of NF-ĸB at 276th serine residue. These
modiﬁcations enhance the interaction of NF-ĸB with P300 and promote the recruitment of the positive
transcription elongation factor b (P-TEFb) to the HIV-1 LTR, supporting the development of an open/
relaxed chromatin conﬁguration, and facilitating the initiation and elongation phases of HIV-1
transcription. Results are also conﬁrmed in primary monocyte derived macrophages (MDM). Overall,
our study provides detailed insights into cocaine-driven HIV-1 transcription and replication.
& 2015 Elsevier Inc. All rights reserved.
Introduction
Cocaine is one of the most widely abused drugs in the United
States and remains a signiﬁcant cofactor for human immunodeﬁ-
ciency virus type 1 (HIV-1) infection and transmission. In addition
to increasing the severity of the infection, cocaine impairs the
normal function of the cells within the brain and promotes HIV-1
replication in the central nervous system (CNS) (Nath et al., 2002,
2001). The long-lived CNS glial cells, microglia, macrophages and
astrocytes are the main targets and reservoirs of HIV-1 infection in
the brain (Nath et al., 2002, 2008). Previous studies reported that
HIV-1 infected individuals who abuse cocaine experience a more
severe and rapid onset of neuro-acquired immunodeﬁciency
syndrome (neuroAIDS) than non-abusing individuals (Anthony
et al., 1991; Chiasson et al., 1990; Ioannidis et al., 2000; Nath
et al., 2001; Parikh et al., 2014). It has been well established
that cocaine modulates several signaling pathways primarily
MAPK pathway, PI3K/Akt pathway and PKC signaling pathways
(Estaquier et al., 2013; Ioannidis et al., 2000; Liu et al., 2000; Nath
et al., 2000; Parikh et al., 2014; Skalka, 2013), which result in the
activation of downstream protein factors, including transcription
factors. These downstream transcription factors in addition to
modifying the expression of cellular genes, modulate the expres-
sion of integrated HIV-1 proviruses and ultimately enhance HIV-1
replication, transmission and HIV-1-associated neurological dis-
orders (HAND) (Hauser et al., 2006; Nath et al., 2000, 2002).
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However, the mechanism underlying the complex interplay
between drugs of abuse and HIV-1 replication is still uncertain.
Similar to the transcription of most cellular genes, HIV-1
transcription progresses through two major phases, initiation
and elongation, in order to generate full viral genomic transcripts
(Estaquier et al., 2013; Kilareski et al., 2009; Kobor and Greenblatt,
2002; Krogan et al., 2002; Liu et al., 2000; Nath et al., 2000; Turk
and Stoka, 2007). Transcriptional initiation efﬁciently starts when
transcription factors such as speciﬁcity protein 1 (Sp1), nuclear
factor (NF)-κB and nuclear factor of activated T cells (NFAT)
proteins bind to the HIV-1 Long Terminal Repeat (LTR) (Karn,
2011; Kinoshita et al., 1997; Nabel and Baltimore, 1987; Perkins
et al., 1997a). These factors subsequently promote the recruitment
of histone modifying enzymes which establish transcriptionally
active chromatin structures at the HIV-1 LTR and facilitates the
recruitment of other components of transcription machineries at
LTR promoter (Kilareski et al., 2009; Kobor and Greenblatt, 2002;
Krogan et al., 2002; Peterlin and Price, 2006; Turk and Stoka,
2007). RNA polymerase II (RNAP II) initiates the elongation phase
of HIV-1 transcription, but it halts just after generating incomplete
shorter transcripts due to the binding of inhibitory comp-
lexes, which primarily include the negative elongation factor
(NELF) and the 5,6-dicholoro-1-β-D-ribofuranoxylbenzimidazole
(DRB) sensitivity-inducing factor (DSIF) at the HIV-1 LTR (Jad-
lowsky et al., 2014; Zhang et al., 2007). To overcome this inhibi-
tion, HIV-1 has a specialized protein, trans-activator of transcrip-
tion (Tat), that directly interacts with elongation factor and
recruits the host protein complex, positive transcriptional elonga-
tion factor b (P-TEFb) to the HIV-1 LTR (Rockstroh et al., 2011;
Volberding and Deeks, 2010; Wei et al., 1998). P-TEFb consists of
an enzymatic component, cyclin-dependent kinase 9 (CDK9) and
cofactor cyclin T (T1 or T2) (Lee et al., 2006). P-TEFb is required for
the generation of full-length HIV transcripts as the lack of P-TEFb
in quiescent T cells has shown to be one of the major factors that
restrict HIV-1 transcription during latency (Budhiraja et al., 2013;
Tyagi et al., 2010). The recruitment of P-TEFb at the HIV-1 LTR,
primarily facilitated by the Tat protein of HIV-1 (Peterlin and Price,
2006; Wei et al., 1998), enhances the processivity of RNAP II by
hyper-phosphorylating the C-terminal domain (CTD) of RNAP II
(Adelman and Lis, 2012). Moreover, P-TEFb also phosphorylates
the different subunits of inhibitory complexes leading to either
their removal from the LTR or their conversion into positive factors
(Bourgeois et al., 2002; Fujinaga et al., 2004; Isel and Karn, 1999;
Kim et al., 2002; Parada and Roeder, 1996). These events relieve all
the restrictions, allowing the recruitment of a super elongation
complex at HIV-1 LTR, resulting in a productive elongation phase
(He et al., 2011; Liu et al., 2012; Sobhian et al., 2010).
Cocaine activates NF-ĸB, an important transcriptional activator
(Ang et al., 2001; Dhillon et al., 2007; Hou et al., 1996; Yao et al.,
2010). The NF-ĸB family consists of ﬁve related proteins, p65 (Rel
A), Rel B, c-Rel, p50/p105 (NF-ĸB) and p52/p100 (NF-ĸB2) and they
can form homo- or heterodimers with each other (Hayden and
Ghosh, 2004). Of these, one of the best-characterized NF-ĸB
heterodimers is comprised of Rel A (p65) and p50, which widely
expressed and heavily involved in NF-ĸB-regulated transactivation
(Schmitz and Baeuerle, 1991). In its inactive state, the NF-ĸB dimer
is bound to the inhibitory IĸB in the cellular cytoplasm (Hayden
and Ghosh, 2004; Sobhian et al., 2010). Upon stimulation, serine
residues 32 and 36 (S32 and S36) of IĸB are phosphorylated by the
IĸB kinase (IKK) complex, which is composed of IKKα, IKKβ and
IKKγ (Bonizzi et al., 2004; Bonizzi and Karin, 2004; Brown et al.,
1995; Hayden and Ghosh, 2004). This leads to the ubiquitination of
IĸB at lysine residues 21 and 22 (K21 and K22) and leads to the 26S
proteasome degradation and the subsequent activation and
nuclear translocation of NF-ĸB (Brown et al., 1995; Kerr et al.,
1991). During and following nuclear translocation, the p65 subunit
gets phosphorylated at selective serine residues each of which
play a different role in the transcriptional activation of NF-ĸB
(Naumann and Scheidereit, 1994). Phosphorylation of p65 at
serine 536 (S536) promotes its nuclear translocation and is
primarily catalyzed by IKKβ and ribosomal S6 kinase-1 (RSK1)
(Bohuslav et al., 2004; Brami-Cherrier et al., 2005; Chandrakesan
et al., 2010). The phosphorylation of p65 at serine 276 (S276)
enhances its functional activity (Hu et al., 2004) which supports
the association of NF-ĸB with chromatin remodeling enzymes
such as histone acetyltransferase (HATs) (Perkins et al., 1997a;
Vermeulen et al., 2002, 2003; Yao et al., 2010; Zhong et al., 2002).
Mitogen-and stress-activated protein kinase 1 and 2 (MSK1 and
MSK2) are two protein isoforms of MSK that are expressed
predominantly in the nucleus and are involved in cellular prolif-
eration and survival (Dunn et al., 2005; Vermeulen et al., 2003).
Both MSK proteins require a series of phosphorylation steps to
become catalytically proﬁcient, prior to phosphorylating or acti-
vating other proteins in downstream cascades (Dunn et al., 2005;
Vermeulen et al., 2003). MSK1 has been identiﬁed as one of the
kinases that catalyze the phosphorylate histone H3 at its serine
residue 10 (Thomson et al., 1999). MSK enzymes phosphorylate
several protein targets including histones, cyclic AMP-responsive
element binding protein (CREB), ATF1, NF- ĸB, as well as various
AP-1 subunits, such as c-fos and c-jun (Dunn et al., 2005; Panneer
et al., 2014; Soloaga et al., 2003; Vermeulen et al., 2003). In the
context of cocaine, previous studies in a mouse model have shown
a role for MSK1 in the activation of the immediate early gene, c-fos,
and the extracellular signal-regulated kinase (ERK) signaling path-
way in the striatum following cocaine exposure (Ang et al., 2001;
Brami-Cherrier et al., 2005; Dhillon et al., 2007; Hou et al., 1996;
Nowak and Corces, 2004; Yao et al., 2010). However, its role in
human cells and how MSK1 inﬂuences HIV-1 transcription have
never been investigated. In this study, for the ﬁrst time, we
established the important role of MSK1 during HIV-1 transcrip-
tion, by performing a comprehensive investigation using myeloid
cell lines and primary cells. We found that MSK1 promotes both
the initiation and elongation phases of HIV-1 transcription by
catalyzing the phosphorylation of p65 at serine 276, p-p65 (S276)
and histone H3 at serine residue 10, p-H3S10, respectively.
Phosphorylation of p65 subunit of NF-ĸB at serine 276 enhances
the interaction and recruitment of HATs, such as p300 at gene
promoters and the induced euchromatin structures further pro-
motes the access to transcriptional machinery at promoter and
augment the initiation phase of HIV transcription. In parallel MSK1
induced p-H3S10 epigenetic modiﬁcation, besides facilitating the
establishment of transcriptionally active chromatin structures
promotes the recruitment of P-TEFb to the HIV LTR (Ivaldi et al.,
2007; Kizaki et al., 2009; Itzen et al., 2014). Consequently, cocaine
is able to accelerate HIV-1 transcription by promoting both
initiation and elongation of viral transcripts via activating NF-ĸB
and MSK1.
Results
Cocaine enhances HIV-1 gene expression
THP-1 cells were infected with a HR0P-Luc pseudotyped virus
which is an HIV-1 based lentivirus expressing luciferase reporter
gene under the control of HIV-1 LTR promoter (Dull et al., 1998;
Pearson et al., 2008; Tyagi and Karn, 2007; Zufferey et al., 1998).
The cells were treated with different concentrations of cocaine,
2.5 μM, 5 μM and 10 μM for 48 h. These cells were then lysed
and the level of the reporter protein expression was determined
by the luciferase assay. It was shown that cocaine treatment
induced HIV gene expression in a dose-dependent manner
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(Fig. 1A). Speciﬁcally, incubation with 5 mM of cocaine led to an
approximate 2-fold increase in HIV-1 transcription (Fig. 1A). Fol-
lowing incubation, we determined if the effect of cocaine treat-
ment on viral transcription observed in THP-1 cells held true in
other monocytic cell-types. 5105 primary monocyte derived
macrophages (MDM) or U937 cells were plated in 12-well plates,
followed by pre-incubation with 1, 5 or 10 mM cocaine for 15 h
prior to infection with the HIV-1NL4-3-ΔE-EGFP VSV-G pseudotyped
virus. We observed that after seven days of daily cocaine treat-
ment, there is a dose-dependent increase in the GFP expression,
indicating an increase in HIV-1 gene expression within the
infected MDM cells (Fig. 1B–E). Similarly, cocaine treatment
increased the expression of GFP after only two days infection in
a dose-dependent manner in U937 cells (Fig. 1F–I). Although the
10 mM dose of cocaine produced the strongest response in the cell
lines tested, the 5 mM concentration dose was chosen for all
Fig. 1. Cocaine accelerates HIV-1 transcription in a dose-dependent manner in THP-1, U937 and Monocyte-derived Macrophages (MDMs). (A) THP-1-pHR0-P-Luc cells were
treated with 2.5–10 mM of cocaine for 48 h. The cells were lysed and the luciferase assay was performed on the cell lysates. In all treated samples luciferase levels were
calculated as a percentage of the untreated group. Statistical analysis was done in 3 experiments n po0.05, nn po0.01 vs. unstimulated control. MDM and U937 cells were
pre-incubated with 1, 5 or 10 mM cocaine for 15 h then treated with the HIV-1NL4-3-ΔE-EGFP VSVG-pseudotyped virus. The primary MDM cells were further exposed to cocaine
once daily for 7 days, and GFP expression within (B) untreated and (C) 1 mM, (D) 5 mM and (E) 10 mM cocaine-treated MDM was analyzed by FACS. GFP expression within the
(F) untreated and (G) 1 mM, (H) 5 mM and (I) 10 mM cocaine-treated U937 cells was assessed two days after cocaine treatment. Statistical analysis was done from 3 separate
experiments; n po0.05, nn po0.01 vs. unstimulated control.
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subsequent experiments because it fell well within physiological
range and could still signiﬁcantly stimulate the cells (Nair, 2000).
In addition, there was no decrease in cell viability following
cocaine treatment as determined by trypan blue (data not shown).
Cocaine enhances the nuclear translocation of NF-ĸB in HIV-1
infected cells
The activation of HIV-1 gene expression involves the interac-
tion of several transcription factors with speciﬁc DNA binding sites
within HIV-1 LTR. NF-ĸB is one of the nuclear proteins that play an
important role in the expression of several cellular genes, and its
binding sites are found within HIV-1 LTR (Kilareski et al., 2009;
Nabel and Baltimore, 1987). Therefore, the activation of NF-ĸB
upon cocaine treatment was assessed in our system. THP-1 cells
were infected with replication incompetent HIV-1 (NL4-3-ΔE-
EGFP) overnight. The following day, the NL4-3-ΔE-EGFP virus
infected-cells were treated with 5 mM cocaine for different time
intervals (30 min to 6 h) in our acute cocaine intake model. The
translocation of NF-ĸB, from cytoplasm to nucleus was evaluated
by western blotting using cytoplasmic and nuclear fractions.
The nuclear levels of the p65 subunit of NF-ĸB signiﬁcantly
increased following cocaine treatment with more than 2 fold at
30 min and peaking at around 3 h (Figs. 2B and S1). Corresponding
decrease in the cytoplasmic levels of p65 was quite evident
(Figs. 2A and S1), illustrating the nuclear translocation of cyto-
plasmic p65 protein following cocaine treatment. Nuclear translo-
cation of p65 was even more pronounced in case of TNF-α
treatment, which is one of the strongest and speciﬁc activators
of NF-ĸB. Although cocaine is not as potent as TNF-α in inducing
the translocation of NF-ĸB, cocaine nevertheless is a highly
efﬁcient activator of NF-ĸB. Similarly, the nuclear translocation of
NF-ĸB was also observed in our chronic model of cocaine treat-
ment although not as profound as in acute model. In the chronic
model of cocaine treatment cells were treated repeatedly for
3 days with 5 mM of cocaine every 12 h in order to mimic
chronic/repeated cocaine intake conditions (Fig. 2C and D). In
the chronic model p65 levels peak at 48 h. Longer treatment (72 h)
did not enhance p65 levels further. Together, these results sug-
gested that cocaine intake promotes HIV-1 gene expression by
enhancing both the nuclear translocation and functional activity of
NF-ĸB (detailed in the following sections).
Cocaine activates NF-ĸB by enhancing its phosphorylation at serine
residue 536
It has been well established that the phosphorylation of p65
subunit of NF-kB at serine residue 536 (S536) promotes and marks
the nuclear translocation of NF-ĸB due to its uncoupling from the
cytoplasmic inhibitory IĸB complex (Bohuslav et al., 2004;
Chandrakesan et al., 2010, 2010; Brami-Cherrier et al., 2005;
Hayden, 2012). Therefore, we assessed the p65 subunit phosphor-
ylation at S536 following cocaine treatment to determine if this
was part of the molecular mechanism of NF-ĸB activation by
cocaine in HIV-infected cells. The NL4-3-ΔE-EGFP virus infected
THP-1 cells were treated with 5 mM cocaine acutely and chroni-
cally. We found cocaine treatment greatly enhanced the phosphor-
ylation of S536 of p65, P-p65(S536) (more than 4 fold within
30 min) and remain higher even after 6 h (Fig. 3B). However,
cytoplasmic levels of P-p65(S536) did not show signiﬁcant change
following cocaine exposure (Fig. 3A). Stimulation with TNF-α was
used as a positive control and resulted in a substantial increase in
p65 phosphorylation at serine 536 (more than 6 folds, Fig. 3B).
Interestingly, analogous to the nuclear translocation of p65
(Fig. 2D), we found a similar pattern of S536 phosphorylation
during chronic cocaine treatment (Fig. 3D), with peak
phosphorylation at 48 h. Overall, the results so far have shown
that cocaine enhances HIV gene expression by activating NF-ĸB.
Cocaine enhances nuclear translocation of NF-ĸB by activating IKKβ
and RSK1
It is established that in addition to inhibitory kappa B (IĸB)
phosphorylation, the ribosomal S6 kinase-1 (RSK1) and IĸB kinase
(IKK) complexes catalyze the phosphorylation of p65 at S536, and
facilitate the nuclear translocation of NF-ĸB (Bohuslav et al., 2004;
Chandrakesan et al., 2010; Brami-Cherrier et al., 2005; Hayden,
2012; Hu et al., 2004; Naumann and Scheidereit, 1994). Therefore,
the cell extracts from cocaine treated NL4-3-ΔE-EGFP virus
infected THP-1 cells were analyzed for the functionally active
(phosphorylated) forms of IKKβ (Tyr 199) and RSK1 (Thr 359) both
in acute and chronic cocaine treatment models. Following acute
cocaine treatment, we found a sizeable increase in the phosphor-
ylation level of IKKβ (Fig. 4A) at 30 min, whereas total IKKβ protein
level signiﬁcantly increases from 30 min to 3 h and then returns to
basal level at 6 h. In our chronic model, we observed that,
phosphorylated forms of IKKβ (Tyr 199) increases for up to 48 h
of cocaine treatment and then return to basal level at 72 h; we
found no change in the level of total IKKβ in the chronic cocaine
treatment model (Fig. 4B).
In the case of RSK1, there was a signiﬁcant increase in the
phosphorylation level of RSK1 at threonine residue position 359
(T359) in both acute and chronic cocaine treatment (Fig. 4C and D),
showing the induction of catalytically active forms of RSK1. In
contrast, the total RSK1 levels were essentially constant. These
results ﬁrmly establish the role of these enzymes in catalyzing the
phosphorylation of p65 at S536 following cocaine administration.
Cocaine enhances NF-ĸB functional activity by promoting its
phosphorylation through MSK1 activation
The phosphorylation of p65 at S276, primarily catalyzed by
MSK1, has been shown to enhance the functional activity of NF-ĸB
by facilitating its interaction with histone acetyl transferases
(HATs) (Perkins et al., 1997b; Vermeulen et al., 2003; Zhong et
al., 2002). In mouse striatum cocaine was reported to activate
MSK1 (Brami-Cherrier et al., 2005). We therefore hypothesized
that cocaine-activated MSK1 could lead to the phosphorylation of
p65 at S276 in human myeloid cells. The NL4-3-ΔE-EGFP virus
infected THP-1 cells were acutely treated with 5 mM cocaine.
Cytoplasmic and nuclear extracts were subsequently examined
by Western immunoblotting using an antibody against the phos-
phorylated form of p65 at Ser 276, P-p65 (S276). We found that
cocaine treatment substantially enhanced the phosphorylation of
p65 at S276 in the nucleus (Fig. 5B). However in the cytoplasm, we
did not detect the phosphorylation of p65 at S276 (Fig. 5A). TNF-α
treated cells were used as a positive control. In our chronic model
of cocaine treatment, the levels of P-p65 (S276) peaked at 48 h,
however further cocaine treatment resulted in its reduction; akin
to the total p65 levels (Fig. 2D). Similar to the acute treatment, we
did not detect P-p65 (S276) in the cytoplasmic fraction of chroni-
cally treated cells (Fig. 5C).
In parallel experiments, NL4-3-ΔE-EGFP virus infected THP-1
cells were treated with 5 mM cocaine and the activation of MSK1
was assessed by evaluating the phosphorylation of MSK1 at
threonine residue 581 (T581), a critical modiﬁcation that indicates
the functionally active form of MSK1 (McCoy et al., 2005). As
anticipated, analogous to the phosphorylation of p65 (S276)
(Fig. 5B and D), we noticed markedly enhanced phosphorylation
of MSK1 at T581 in nucleus, following cocaine exposure (Fig. 6B
and D). Notably, a rapid activation of MSK1 upon acute cocaine
exposure was observed (Fig. 6B). During chronic cocaine treatment
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we also found sizable MSK1 phosphorylation. Interestingly we
detected a corresponding loss of unphosphorylated form of MSK1,
especially during chronic treatment (Fig. 6D).
The lack of phospho-p65 (S276) in the cytoplasmic fraction
(Fig. 5A and C) was further conﬁrmed by the absence of the
functionally active form of MSK1 (Fig. 6A and C). Thus, direct
correlation between phospho-MSK1 (T581) and phospho-p65
(S276) levels suggests that MSK1 is the primary kinases that
catalyzes the phosphorylation of the p65 subunit, speciﬁcally at
S276 following cocaine exposure, thereby enhancing the func-
tional activity of NF-ĸB.
Cocaine activated MSK1 promotes histone H3 phosphorylation
The functional role of the phosphorylation at the serine residue
10 of histone H3 (H3S10) during transcription was highlighted by
the recent discovery that this event is crucial for recruiting P-TEFb
to the gene promoters via the bromodomain protein 4 (Brd4)
(Itzen et al., 2014; Kizaki et al., 2009). Accordingly, the temporal
changes in the phosphorylation of H3S10 (p-H3S10) were inves-
tigated in the cocaine treated NL4-3-ΔE-EGFP virus-infected THP-1
cells by western blotting. In parallel to the observed MSK1
activation kinetics, a signiﬁcant increase in the level of p-H3S10
was observed just after 30 min of cocaine treatment (Fig. 7A).
Furthermore, similar to the levels of MSK1 activation, the higher
levels of p-H3S10 persisted for up to 72 h in the chronic treatment
model (Fig. 7B). In order to conﬁrm the direct role of MSK1 in
catalyzing p-H3S10 phosphorylation, we analyzed the impact of
the MSK1 inhibitor, RO31-8220 (Santa Cruz), in restricting MSK1
activity and corresponding H3S10 phosphorylation. The potent
inhibition of cocaine-induced MSK1 activation was observed
following 1 h pre-incubation with 5 mM RO31-8220 (Fig. 7C). This
Fig. 2. Cocaine exposure signiﬁcantly enhances the nuclear translocation of NF-ĸB in both acute and chronic models of cocaine treatment. HIV-1 infected THP-1 cells were
treated either acutely (A and B) or chronically (C and D) with 5 mM cocaine. For acute exposure, cells were treated once with 5 mM cocaine for indicated time intervals;
whereas for chronic treatment cells were treated twice a day for up to 3 days. Subsequently, the nuclear translocation kinetics of NF-ĸB from cytoplasm was assessed by
probing for p65 subunit. For cytoplasmic fractions (A and C) GAPDH was used as loading control; while Lamin A/C was used as loading control for nuclear fractions (B and D).
As positive control for NF-ĸB activation, cells were treated with TNF-α (10 ng/mL). Densitometric analysis was done on all immunoblots and statistical analysis was done
from 5 experiments; n po0.05, nn po0.01 vs. unstimulated control.
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inhibition also coincided with a signiﬁcant decrease in H3S10
phosphorylation induced by cocaine (Fig. 7D). These results con-
ﬁrm that cocaine activated MSK1 plays a major role in H3S10
phosphorylation following cocaine treatment.
Cocaine activated IKKα too promotes histone H3 phosphorylation
Besides MSK1, several other enzymes are known to catalyze the
phosphorylation of H3S10. IKKα is a primary example of such an
enzyme. In order to determine whether cocaine activates IKKα, we
treated NL4-3-ΔE-EGFP virus-infected THP-1 cells acutely and chroni-
cally with cocaine. Western blots were performed using antibody
speciﬁc to the phosphorylated form of IKKα, p-IKKα (S176/180). The
nuclear levels of p-IKKα (S176/180), which indicates the catalytically
active form peaked at 30 min (Fig. 8B) and showed a clear relation to
the H3S10 phosphorylation (Figs. 7A and 8B). During chronic treat-
ment p-IKKα (S176/180) remained elevated after 72 h post treatment
(Fig. 8D). Similar to p-MSK1 (Fig. 6A and C), the catalytically active
phosphorylated form of IKKα is exclusively present in the nuclear
fraction, where its substrate, p-H3S10 resides, suggesting a clear role
of IKKα in catalyzing phosphorylation of H3S10 (Fig. 8A and C).
Moreover, cocaine also enhanced the overall levels of IKKα in the
nucleus (Fig. 8B and D). However, cytoplasmic levels of IKKα were
unaffected upon cocaine exposure (Fig. 8A and C).
In order to determine the role of IKKα in catalyzing p-H3S10
phosphorylation during cocaine exposure, we analyzed the impact
of the IKKα inhibitor, BAY11-7082 (Santa Cruz) on restricting IKKα
activity and analyzed the impact on IKKα-induced H3S10 phos-
phorylation. The robust inhibition of cocaine-induced IKKα activa-
tion by BAY11-7082 was quite evident (Fig. 9A). However, strong
Fig. 3. Cocaine enhances phosphorylation of the p65 subunit of NF-ĸB at S536. Phosphorylation of cytoplasmic and nuclear NF-ĸB at serine 536 was assessed by
immunoblotting following acute (A and B) or chronic (C and D) cocaine exposures to HIV-infected THP-1 cells for indicated time periods. GAPDH and Lamin A/C were used as
loading controls for cytoplasmic and nuclear extracts, respectively. Cells treated with 10 ng/mL TNF-α were used as positive control. Densitometry analysis was done for all
immunoblots. Densitometry analysis was done on all immunoblots and statistical analysis was done from 5 experiments; n po0.05, nn po0.01 vs. unstimulated control.
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Fig. 4. Cocaine promotes the nuclear translocation of NF-ĸB by activating IKKβ and RSK1. The cell lysates of the HIV-1-infected THP-1 cells were examined for the stimulation
of the total and phosphorylated forms of IKKβ and RSK1 at tyrosine 199 and threonine 359, respectively. Total and the catalytically active, phosphorylated, forms of enzymes
were analyzed by immunoblotting following acute (A and C) or chronic (B and D) cocaine exposures to HIV-infected THP-1 cells for time periods as indicated. GAPDH was
used as loading control for cytoplasmic fraction and Lamin A/C for nuclear fraction. Densitometry analysis was done on all immunoblots and statistical analysis was done
from 5 experiments; n po0.05, nn po0.01 vs. unstimulated control.
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inhibition of IKKα did not translate into proportional p-H3S10
inhibition (Fig. 9B). These results conﬁrmed that IKKα surely
contributes to overall cocaine induced p-H3S10 phosphorylation,
but plays a subordinate role to MSK1 in catalyzing H3S10 phos-
phorylation following cocaine treatment.
Cocaine promotes HIV-1 transcription by enhancing the recruitment
of both initiation and elongation factors in addition to establishing
transcriptionally active chromatin structures at HIV-1 LTR
Chromatin modiﬁcation is a crucial step to initiate transcription
of most eukaryotic genes (Kouzarides, 2007; Nowak and Corces,
2004). Although the proteins that induce chromatin reorganiza-
tion play critical roles during overall transcription, their primary
effect occurs during the initiation phase of transcription (Gray et
al., 1999; Thorne et al., 2009). Therefore, in order to determine the
factors involved in HIV-1 transcription following cocaine treat-
ment, we analyzed their recruitment and resultant epigenetic
modiﬁcations at the HIV-1 LTR by performing chromatin immu-
noprecipitation (ChIP) assays.
THP-1 cells were infected with HIV-1NL4-3-ΔE-EGFP and treated
with cocaine for either 1 h or 6 h followed by ChIP assays. The
immunoprecipitated DNA was analyzed for the recruitment of
different transcription and epigenetic factors and the changes in
epigenetic modiﬁcations at both the promoter and nucleosome-1
(Nuc-1) regions using primer sets speciﬁc for the indicated regions
as detailed in the Materials and methods section. As demonstrated
above, via activating MSK1, cocaine enhances the functional
activity of NF-ĸB by promoting the phosphorylation of p65 at
S276. The recruitment of p-p65 (S276) was analyzed and we found
more than 2-fold enhanced recruitment of p-p65 within 1 h and
remained signiﬁcantly elevated even after 6 h post-cocaine treat-
ment at promoter (Fig. 10A and C). In agreement with the
established ﬁndings that the phosphorylation of p65 at S276
enhances the interaction of NF-ĸB with histone acetyl transferases
(HATs), we found higher recruitment of P300 at the HIV-1 LTR
after cocaine exposure (Fig. 10A and B). Concomitantly, we found a
rapid loss of histone deacetylase 3 (HDAC3) from the LTR upon
cocaine treatment; the higher ratio of HATs to HDACs translated
into enhanced acetylation of core histones H3 (H3-Ac) and H4
Fig. 5. Phosphorylation of the p65 subunit at serine 276 is signiﬁcantly increased during both acute and chronic cocaine treatments. HIV-1 infected THP-1 cells were treated
with 5 mM cocaine acutely (A and B) or chronically (C and D) for different time intervals. NF-ĸB phosphorylated at serine 276 (p-p65 (Ser 276) was assessed by Western
immunoblotting. GAPDH is used as a loading control for cytoplasmic extract (A and C) and Lamin A/C used as a loading control for nuclear extract (B and D). Cells treated
with 10 ng/mL TNF-α were used as positive control. Densitometry analysis was done on all immunoblots and statistical analysis was done from 5 experiments; n po0.05, nn
po0.01 vs. unstimulated control.
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Fig. 6. Cocaine profoundly activates MSK-1 during both acute and chronic cocaine exposures. We characterized the impact of cocaine in inducing catalytically active form of
MSK1, besides total MSK1 levels, after treating HIV-1 infected THP-1 cells with 5 mM cocaine either acutely (A and B) or chronically (C and D). The cytoplasmic and nuclear
fractions of the cells were probed with antibody speciﬁc for phospho-MSK1 at threonine 581 (T581) and total MSK1 antibody. GAPDH was used as loading control for
cytoplasmic fraction and Lamin A/C for nuclear fraction. Densitometry analysis was done on all immunoblots and statistical analysis was done from 5 experiments; n po0.05,
nn po0.01 vs. unstimulated control.
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(H4K12-Ac) at the HIV-1 LTR (Fig. 10A-D). The H3-Ac and H4K12-
Ac are euchromatic marks, which represent the establishment of
transcriptionally active open chromatin structures at the HIV-1
LTR allowing access to transcription machinery (Ishida et al., 2006;
Nakayama et al., 2001; Nakayama and Takami, 2001; Xu
et al., 2003). This is evidenced by the elevated presence of RNA
polymerase II (RNAP II) following cocaine treatment representing
enhanced ongoing HIV-1 transcription (Fig. 10A–D). Upon cocaine
treatment, a rapid, concurrent loss of several heterochromatic
marks from the LTR, including trimethylated histone H3 at lysine
positions 9 (H3K9-me3) and lysine position 27 (H3K27-me3)
(Fig. 10C and D) further validate the establishment of transcrip-
tionally active chromatin structures at LTR.
We demonstrated earlier that MSK1 catalyzes the phosphorylation
of histone H3 at the serine residue 10 (P-H3S10) (Fig. 7) which
suggests the recruitment of MSK1 at HIV LTR. The enhanced
recruitment of MSK1 at HIV LTR following cocaine treatment was
observed (Fig. 10A and B). The enrichment of MSK1 at promoter was
greater than on Nuc-1 region (Fig. 10A and B), and accordingly the
enhanced recruitment of MSK1 translated into higher levels of p-
H3S10 to the HIV-1 LTR following cocaine treatment (Fig. 10C and D).
Similar to our western blotting analysis, levels of H3S10 phosphoryla-
tion remained signiﬁcantly upregulated even after 6 h of cocaine
exposure (Figs. 7, 10C and D). Besides contributing to the establish-
ment of transcriptionally active chromatin structures, H3S10 phos-
phorylation promotes the recruitment of P-TEFb, which is indicated by
the recruitment of cyclin T1 to the HIV-1 LTR following cocaine
treatment (Fig. 10C and D). It is noteworthy that the presence of p-
H3S10 and H4K12-Ac marks newly reorganized chromatin structures
(Strahl and Allis, 2000). The accumulation of p-H3S10 and H4K12-Ac
epigenetic marks following cocaine treatment further validates our
hypothesis that cocaine enhances HIV-1 transcription by modifying
Fig. 7. Cocaine augments the phosphorylation of H3S10 via MSK1 activation. HIV-1-infected THP-1 cells were treated with acutely and chronically with 5 mM cocaine (A and
B), lysed and the nuclear fraction sonicated and analyzed for the phosphorylated form of H3S10 by immunoblotting. Total Histone H3 was used as a loading control. In panel
(C) and (D), cells were pre-treated with MSK1 inhibitor RO31 (3 mM and 5 mM) for 1 h, before treating them with cocaine (5 mM) for 30 min. Nuclear fractions were assessed
for p-MSK1 (C) and p-H3S10 (D) before and after treating cells with MSK1 inhibitor RO31 (5 mM). Densitometry analysis was done on all immunoblots and statistical analysis
was done from 4 experiments; n po0.05, nn po0.01 vs. unstimulated control.
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Fig. 8. Cocaine activates IKKα in both in acute and chronic cocaine model. The cytoplasmic and nuclear protein fraction of HIV-1-infected THP-1 cells treated either acutely (A
and B) or chronically (C and D) with 5 mM cocaine were probed with antibodies against unphosphorylated and phosphorylated catalytically active forms of IKKα. Cytoplasmic
(A and C) and nuclear fractions (B and D) were analyzed. GAPDH was used as a loading control for cytoplasmic fraction and Lamin A/C for nuclear fraction. Densitometry
analysis was done on all western immunoblots. Densitometry analysis was done on all immunoblots and statistical analysis was done from 3 experiments; n po0.05, nn
po0.01 vs. unstimulated control.
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chromatin structures at the LTR. Overall, these results conﬁrm that
cocaine exposure converts transcriptionally repressive chromatin
(heterochromatin) structures into transcriptionally active chromatin
(euchromatin) structures at the HIV-1 LTR.
Considering that the resolution of the ChIP assays range
between 500 and 700 base pairs (bp), some signal overlap
between the promoter and Nuc-1 regions of the LTR was expected.
Accordingly, we found some overlap of signal; nevertheless, as
Fig. 9. IKKαmodestly support cocaine induced overall H3S10 phosphorylation: HIV-1 infected THP-1 cells were pre-treated with the IKKα inhibitor BAY-11 (3 mM and 5 mM)
for 1 h prior to incubation with 5 mM cocaine for 30 min. The nuclear levels of IKKα (A) and p-H3S10 (B) were determined by immunoblotting. SPT5 was used as loading
control for IKKα and Histone 3 for phosphorylated H3S10. Statistical analysis was done from 4 experiments, n po0.05 and nn po0.001 vs. unstimulated control.
Fig. 10. Cocaine activated NF-kB enhances HIV-1 gene expression by recruiting P300 at the HIV-1 LTR, which acetylate the core histones and establish transcriptionally active
chromatin structures at the HIV-1 LTR. HIV infected THP-1 cells were treated with 5 mM cocaine for either 1 h or 6 h. The chromatin immunoprecipitation (ChIP) analysis
was performed to evaluate the reorganization of chromatin structure at HIV-1 LTR following cocaine treatment in order to measure the changes in selective epigenetic
modiﬁcations. We also assessed the recruitment of different transcription factors and epigenetic enzymes at LTR. (A and C) Primer sets directed to the Promoter region (116
to þ4 with respect to transcription start site); (B and D) Nucleosome 1 (þ30 to þ134 with respect to transcription start site) of HIV-1 LTR. The depicted ChIP assay results
were reproduced more than 7 times.
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anticipated, p65 is largely restricted to its binding sites, which
exist near the promoter region (Fig. 10A–D).
Previous studies established that AP-1 is activated efﬁciently by
cocaine treatment (Nestler, 2012). Therefore, as a positive control,
we assessed the recruitment of the c-Jun subunit of AP-1 at HIV-1
LTR (Fig. 10A and B). Possibly resulting from cocaine degradation in
the cell culture milieu and/or cocaine receptor internalization/
desensitization after 6 h, the levels of all the factors at the HIV-1
LTR decreased. Interestingly, however, despite the reductions in
the recruitment of most of the transcription factors at the LTR,
histone modiﬁcations (acetylation and phosphorylation) and the
recruitment of AP-1 to its downstream binding sites were still
increasing (Fig. 10A and B).
Thus, cocaine appears to facilitate HIV-1 transcription by
promoting the recruitment of transcription factors involved in
both the initiation and the elongation phases of HIV-1 transcrip-
tion. This eventually results in the removal of heterochromatin
structures and leads to the establishment of euchromatin struc-
tures at LTR, promoting HIV-1 transcription.
Cocaine promotes HIV transcription by activating NF-kB and MSK1 in
primary monocyte-derived macrophages (MDM)
In Fig. 1 we demonstrated that cocaine enhances HIV-1 gene
expression in primary monocyte derived macrophages (MDM) in a
dose dependent manner (Fig. 1B–E). In order to further establish the
role of cocaine in physiologically more relevant primary MDM cells,
the MDMs were treated with either 1 or 5 mM cocaine for 30 min. The
cytoplasmic and nuclear fractions were assessed to examine the
degree of activation of different factors and post-translational mod-
iﬁcation. As expected, similar to the results observed in the THP-1 cell
line, western blot analysis of MDM showed a dose-dependent increase
in the nuclear levels of total NF-ĸB, p-p65 (S536) and p-p65 (S276),
following cocaine exposure (Figs. 11A–C and S2). Additionally, we also
found enhanced of MSK1 phosphorylation at threonine 581 (T581)
(Fig. 11D) as well as phosphorylation of histone H3 at serine 10
(Fig. 11E) following cocaine treatment.
Discussion
In this study the molecular mechanisms by which cocaine
enhances HIV-1 gene expression during acute and chronic cocaine
exposure have been explored, and the key steps/pathways through
which cocaine enhances HIV-I transcription have been elucidated. We
have shown that cocaine promotes HIV-1 transcription by activating
both NF-ĸB and MSK1. More importantly, results from primary MDM
cells conﬁrmed the activation of NF-ĸB and MSK1 following cocaine
treatment. In both cell types, we found NF-ĸB and MSK1 activation
rose sharply following cocaine exposure. When we examined HIV-1
gene expression in infected primary MDM and U937 cells by Flowcy-
tometric (FACS) analysis, corresponding increase in GFP expression
following cocaine treatment was found. These results strongly support
the concept that cocaine-induced activation of NF-ĸB and MSK1 drives
HIV-1 transcription and replication within monocytes/macrophages
lineages.
The importance of NF-ĸB in inducing HIV-1 transcription
(Nabel and Baltimore, 1987) and activation of NF-ĸB by cocaine
have been demonstrated by several previous studies (Ang et al.,
2001; Dhillon et al., 2007; Hou et al., 1996; Yao et al., 2010).
However, the underlying molecular mechanisms through which
cocaine modulates NF-ĸB activation were not well deﬁned. In this
study we have demonstrated that in addition to stimulating IKKβ,
cocaine profoundly activates ribosomal S6 kinase-1 (RSK1); both
enzymes besides inducing the phosphorylation of IĸB, catalyze the
phosphorylation of the p65 at serine residue 536, a marker of
nuclear translocation or activation of NF-kB (Bohuslav et al., 2004;
Chandrakesan et al., 2010; Brami-Cherrier et al., 2005; Hayden,
2012). Furthermore, we found that MSK1 is speciﬁcally activated
by cocaine, as TNF-α was unable to activate MSK1. The ﬁndings in
our study have shown that cocaine-activated MSK1 plays a pivotal
role in HIV-1 gene expression by facilitating both the initiation and
elongation phase of HIV-1 transcription. These ﬁndings provide,
for the ﬁrst time, a comprehensive analysis of the important role
of MSK1 in supporting HIV-1 transcription. In addition to inducing
the levels of MSK1, cocaine stimulates its functional activity by
enhancing its phosphorylation at threonine residue 581 (T581),
which is a marker of the catalytically active form of MSK1 (Arthur,
2008; Markou and Lazou, 2002; Zhong et al., 1998). Cocaine
activated MSK1 subsequently phosphorylates the p65 subunit of
NF-ĸB selectively at serine residue 276 (S276). This phosphoryla-
tion event is known to augment the interaction of p65 with
histone acetyl transferases (HATs), such as P300 and consequently
enhances the transcriptional ability of NF-ĸB (Perkins et al., 1997b;
Vermeulen et al., 2003; Zhong et al., 2002). As result, we found
enhanced recruitment of histone acetyltransferase, such as p300,
to the HIV-1 LTR. HATs subsequently catalyze the acetylation of
core histones and, as a result, higher amounts of hyperacetylated
forms of histone H3 and H4 (H3-Ac and H4K12-Ac) were found at
the HIV-1 LTR. Concurrently cocaine treatment triggers the
removal of heterochromatin marks, including reduction in the
trimethylation of histone H3 at K9 (H3K9-Me3) and K27 (H3K27-
Me3) from the HIV-1 promoter. These epigenetic changes have
resulted in the establishment of transcriptionally active, open
chromatin structures at the HIV-1 LTR that further promotes the
access of transcription machineries at the promoter. This concept
is highly supported by our results showing several fold enrichment
of RNAP II at the LTR upon cocaine treatment. All of these events
facilitate the initiation of HIV-1 transcription.
In addition to phosphorylating the p65 subunit of NF-ĸB at
serine 276, MSK1 also catalyzes the phosphorylation of histone H3
at serine 10 (p-H3S10), and both of these events correlate well
with the kinetics of MSK1 activation following cocaine treatment.
Furthermore, we found enhanced recruitment of MSK1 at HIV LTR
after cocaine treatment. Accordingly, inhibiting MSK1 activity by a
speciﬁc inhibitor caused a signiﬁcant reduction in cocaine-induced
H3S10 phosphorylation, further establishing the direct role of
MSK1 in catalyzing these modiﬁcations. Along with MSK1 several
other enzymes are known to catalyze the phosphorylation of
H3S10, which we plan to investigate in detail in our future studies,
IKKα is one of them. We found efﬁcient activation of IKKα upon
cocaine treatment; however our inhibition studies clearly conﬁrm
the predominant role of MSK1 in catalyzing H3S10 phosphoryla-
tion during cocaine exposure. p-H3S10 is a euchromatic mark,
which contributes to the establishment of transcriptionally active
chromatin structure (Soloaga et al., 2003; Wei et al., 1998). Hence,
we found higher levels of p-H3S10 in the nucleus and its enrich-
ment at HIV-1 LTR after cocaine treatment, again demonstrating
the establishment of transcriptionally active chromatin structures
at HIV-1 LTR following cocaine treatment.
Besides facilitating the establishment of transcriptionally active
chromatin structures, p-H3S10 promotes the recruitment of P-
TEFb to the promoter sites, which in turn leads to the enhanced
processivity of RNAP II (Ivaldi et al., 2007). Accordingly, we found
higher recruitment of P-TEFb to the HIV-1 LTR following cocaine
treatment. The role of P-TEFb in facilitating the elongation phase of
HIV-1 transcription is well established (Bourgeois et al., 2002;
Fujinaga et al., 2004; Ivanov et al., 2000; Karn, 2011; Kim et al.,
2002; Parada and Roeder, 1996; Peterlin and Price, 2006; Wei
et al., 1998). Hence, our results demonstrate that cocaine enhances
HIV-1 gene expression by inducing both the initiation and elonga-
tion phases of HIV-1 transcription by activating NF-ĸB and MSK1.
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Despite the use of highly active antiretroviral therapy (HAART),
the prevalence of HIV-associated neurocognitive disorder or HAND
in drug abusing populations is signiﬁcantly high (Ferris et al.,
2008; Nath et al., 2002, 2001). HIV-1 can be found in the CNS
within days of infection, where it can be present either in a
transcriptionally active or impaired form (Kaul et al., 2001; Nath et
al., 2002, 2001). Within the brain, HIV-1 is harbored primarily in
myeloid cells and these cell types act as the main HIV-1 reservoirs
in the CNS (Nath et al., 2002, 2008). Several viral proteins,
including Tat, Vpr and gp120 are known to contribute to HAND.
In addition, cocaine abuse further accelerates the susceptibility of
the brain to HIV-1 and enhances the severity of neurocognitive
dysfunction in drug abusing HIV-1-infected populations (Anthony
et al., 1991; Chiasson et al., 1990; Dhillon et al., 2007; Goodkin
et al., 1997; Kim et al., 2013; Nath et al., 2001). Thus, consumption
of cocaine remains a signiﬁcant cofactor for HIV-1 infection,
transmission, and consequent neurodegeneration, even in the
era of HAART (Alcabes and Friedland, 1995; Bagasra and
Pomerantz, 1993; Dhillon et al., 2007; Nath et al., 2002; Peterson
et al., 1991; Roth et al., 2002). Since the CNS is the common target
Fig. 11. NF-ĸB is dose-dependently activated in primary monocyte-derived macrophages (MDM) by cocaine treatment. MDM isolated from three healthy donors were
treated with 1 or 5 mM cocaine for 30 min. The cells were lysed, cytoplasmic and the nuclear fractions were probed for (A) p65 (B) p-p65 (S536) (C) p-p65 (S276), (D) p-MSK1
(T581) and (E) p-H3S10 by immunoblotting. GAPDH and Lamin A/C were used as loading controls for cytoplasmic and nuclear extract. Densitometry analysis was done on all
western immunoblots. Densitometry analysis was done on all immunoblots and statistical analysis was done using 3 experiments; n po0.05 and nn po0.01 vs.
unstimulated control.
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for both cocaine and HIV-1, the CNS paradoxically provides an
exclusive opportunity for cocaine and HIV-1 to interact, and in
some instances cooperate synergistically to diminish CNS
function.
Our results, in myeloid cells, provide compelling evidence that
cocaine enhances HIV-1 transcription by promoting both initiation
and elongation phase during either acute or chronic cocaine intake
conditions. Another striking ﬁnding of our study is that both acute
and chronic cocaine treatment activates NF-ĸB and MSK1. How-
ever, upon chronic cocaine treatment NF-ĸB activation is delayed
and comparatively less profound. MSK1 subsequently promotes
the HIV-1 transcriptional initiation by augmenting the functional
activity of NF-ĸB through P-p65 (S276), which enhances the
interaction of NF-ĸB with HATs such as P300. In parallel MSK1
also induces the transcriptional elongation by promoting the
recruitment of P-TEFb at LTR via P-H3S10.
Collectively, our data supports the previous observations and
suggests that cocaine exposure promotes neurodegeneration not
only by inducing the overall replication of HIV-1 (Goodkin et al.,
1997; Nath et al., 2002, 2001), but also by enhancing the cellular
levels of viral proteins such as Tat, Vpr and gp120, which are well
established viral contributors to neurodegeneration during HIV-1
infection (Kaul and Lipton, 2006; King et al., 2006; Kruman et al.,
1998; Mocchetti et al., 2007; Nath et al., 1999). Moreover, NF-κB is
known to induce the expression of several pro-inﬂammatory
genes transcription (Tak and Firestein, 2001) and the involvement
of several pro-inﬂammatory cytokines has already been implicated
in neurodegeneration during HIV-1 infection (Kaul et al., 2005).
Hence, it is quite plausible that besides elevated levels of HIV-1
and its proteins; the up-regulation of several pro-inﬂammatory
cytokines contributes to neurodegeneration via neuroinﬂamma-
tion, during cocaine intake.
We have demonstrated the important role of MSK1 in HIV-1
transcription. Recently, we have also found that MSK1 is a
common target of several pathways that lead to activate HIV-1
transcription, via different stimuli (work in progress). Additional
studies are required to investigate if cocaine also activates MSK1 in
other cell types, especially T cells and, potentially, may have an
impact on replication and latency (work in progress). Moreover,
targeting critical components of these cocaine-induced cascades
could prove beneﬁcial in combination with suppressive HAART,
especially for cocaine abusing HIV-1 patients.
In conclusion, utilizing both myeloid cell lines and primary
human macrophages (MDM), we have demonstrated that cocaine
promotes HIV-1 replication by enhancing HIV-1 transcription
through the activation of NF-ĸB and MSK1. The speciﬁc epigenetic
changes caused by the cocaine activation of these proteins, leads
to the development of a transcriptionally active open chromatin
structures around the HIV-1 promoter. Our ﬁndings further
suggest a previously unknown role for MSK1 in enhancing HIV-1
transcription and replication, more importantly during chronic
cocaine usage. MSK1 prolonged activation leads to extended NF-ĸB
and H3S10 phosphorylation, two of the key events which promote
both the initiation and elongation phases of HIV-1 gene transcrip-
tion. We have uncovered the underlying molecular mechanisms
through which cocaine induces HIV-1 gene expression and pro-
motes neurodegeneration in cocaine using HIV patients.
Materials and methods
Transfection and VSV-G pseudotyped virus generation
Human Embryonic Kidney 293 cells (HEK 293 or 293T) cells
were cultured with RPMI-1640 media supplemented with
2.05 mM L-glutamine (Hyclone, ThermoScientiﬁc), 10% fetal bovine
serum (Gemini), and 1 U/mL penicillin/streptavidin. Cells were
grown to 70–80% conﬂuency and washed with Opti-MEMs
GlutaMAX reduced serum media (Gibco) prior to transfection.
Transfection with Lipofectamine 3000 (Invitrogen) was carried out
according to the manufacturer’s protocol. Brieﬂy, 35 mL of Lipo-
fectamine 3000 reagent was diluted in 500 mL Opti-MEM. In a
separate tube, 18 mg of plasmid DNA mixture (4 mg pMD.G, 3 mg
pCMVΔ 8.9.1, 3 mg pMDL-g/p-RRE, 1 mg pRSV-Rev, and 7 mg of
either pNL4-3-ΔE-EGFP or pHR0-P-Luc, in order to generate a
NL4-3-ΔE-EGFP and a HR0-P-Luc pseudotyped viruses, respec-
tively) (Bonacini et al., 1999; Butler et al., 2001; Dull et al., 1998;
Jadlowsky et al., 2014; Naldini et al., 1996; Zhang et al., 2004) and
35 mL of P3000 reagent were diluted in 500 mL Opti-MEM. The two
separated dilutions were mixed and allowed to incubate at room
temperature for 10 min to form the lipid-DNA complex, which
were then added to the cells. Three to ﬁve hours following the
addition of the transfection cocktail, RPMI culture medium was
added to the cells. The virus containing cell supernatant was
collected at 48 h and 72 h post transfection. The successful gen-
eration of replication incompetent pseudotyped virus expressing
EGFP reporter gene under the control of the HIV-1 LTR was
conﬁrmed by ﬂuorescent microscopy or FACS analysis.
Monocyte-derived macrophages (MDM) isolation
Peripheral blood mononuclear cells (PBMCs) were isolated
from healthy donors by density centrifugation. Brieﬂy, the blood
samples were spun at 400 g for 10 min and the plasma layer
removed. The cells were then diluted with Hank’s balanced salt
saline (HBSS) and layered onto Ficoll- Hypacque (1.077 g/mL; GE
Healthcare) and spun at 2000 rpm for 30 min with no braking. The
PBMC layer was collected, washed once with HBSS and plated in
T75 cell culture ﬂasks in RPMI for 3–4 h at 37 1C. The non-
adherent cells were aspirated, and the remaining adherent mono-
cytes were washed once with RPMI and incubated with media
supplemented with 100 ng/mL M-CSF (Biolegend) for 7 days to
allow for differentiation to macrophages.
Viral titer
The viral titer was assessed by infecting deﬁned number of Jurkat
cells with the different dilutions of concentrated Vesicular Stomatitis
Virus g protein (VSV-G) pseudotyped lentiviral particles. The viral titer
was assessed by calculating the number of GFP positive cells obtained
in higher dilutions of virus. The cell lines were infected with about one
multiplicity of infection (MOI) of viral particles; however for primary
cells we used two MOI of virus.
Cocaine treatment
The cocaine-HCl (referred to as “cocaine” hereafter) was
obtained from National Institute on Drug Abuse (NIDA). The
concentration of cocaine to be utilized was ﬁrst optimized by a
dose–response experiment of cocaine concentration and HIV-1
transcription using THP-1 cells. MDM and human THP-1 mono-
cytic cells were treated with 5 mM cocaine for 10 to 60 min in our
acute model of cocaine treatment. In the chronic model of cocaine
treatment the cells were treated with 5 mM cocaine for 72 h, twice
a day. To assess the effects of cocaine on HIV-1 gene expression,
MDM and U937 cell were pre-incubated with 1–10 mM of cocaine
for 15 h and then treated with the HIV-1NL4-3-ΔE-EGFP pseudotyped
virus. Cocaine was added daily for 7 days to MDM cells and 2 days
to U937 cell and GFP expression levels were then determined by
FACS analysis.
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Cytoplasm and nuclear extract preparation
5106 HIV-1 infected cells were plated in 6-well plates overnight
and incubated with 5 mM cocaine for 30 min to 72 h as indicated in
each experiment. The cells were collected and washed with ice-cold
PBS. The samples were then lysed by incubating on ice for 10 min
with 0.5% NP-40 supplemented with 10 mM HEPES-KOH pH 7.9,
60 mM KCL, 1 mM EDTA, 1 mM DTT, 1 mM PMSF and a protease
inhibitor cocktail (Roche), followed by brief vortexing and centrifuged
for 10 min at 4 1C. The cytoplasmic protein extract was collected and
the remaining nuclear pellet was washed with 500 mL of ice-cold PBS.
The puriﬁed nuclei were then lysed by 6 freeze-thaw cycles in a
buffer comprising of 250 mM Tris pH7.8, 60 mM KCL, 1 mM EDTA,
1 mM DTT, 1 mM PMSF and a protease inhibitor cocktail. The nuclear
protein extract was collected by centrifugation, and solubilized with
5 SDS-PAGE loading buffer. For optimal histone protein isolation,
the nuclear extracts were sonicated by three 10-s pulses. The
sonicated nuclear extract samples were subsequently collected by
centrifugation at 13,000 rpm for 2 min and solubilized with the 5
SDS-PAGE loading buffer.
Western immunoblotting
The cytoplasm and nuclear protein extracts were run on 4–15%
Tris–glycine gels (Bio-Rad) and transferred to nitrocellulose mem-
branes (GE). The proteins of interest were detected by incubating
with primary antibodies such as NFkB-P65(C-20) (Cat. no.: SC-
372), IKKα (Cat. no.: SC-7218), IKKβ (Cat. no.: SC-7329), RSK1 (Cat.
no.: SC-130870), MSK1 (Cat. no.: SC-25417), H3-Histone (Cat. no.:
SC-8654), SPT5 (Cat. no.: SC-28678), GAPDH (Cat. no.: SC-25778),
Lamin A/C (Cat. no.: SC-7292), Phospho-RSK1 (Thr348) (Cat. no.:
SC-101770), Phospho-p65 (Ser 276) (Cat. no.: SC-101749) were
purchased from Santa Cruz Biotechnology. Antibodies against p65
(phospho-S536; Cat. no.: 3033), phospho-MSK1 (Thr 581) (Cat.
no.: 9595), Phospho-IKKα (Ser 176/180) (Cat. no.: 2697) and
phospho-Histone-H3-Serine 10 (Cat. no.: 12201) were purchased
from Cell Signaling. Antibodies against Phospho-IKKβ (Tyr 199)
(Cat. no.: PA5-35838) were purchased from life technologies. The
appropriate secondary antibodies were applied after 3 washes
with 0.05% Tween 20 in phosphate or Tris buffered saline (PBST/
TBST). The blots were incubated with substrate ECL (Santa Cruz)
prior to exposure to X-ray ﬁlm (Fuji). GAPDH, Lamin A/C, Histone
H3 and SPT5 were used as loading controls for cytoplasmic and
nuclear protein fractions. Densitometric analysis on the western
blots was performed using NIH-Image J software.
Chromatin immunoprecipitation (ChIP) assay
ChIP analysis was performed as previously described (Tyagi
et al., 2010). Brieﬂy, (1108) THP-1 cells were infected by the
virus carrying pNL4-3-ΔE-EGFP. In this assay we used 30–40% of
infected cells per antibody. The infected THP-1 cells were stimu-
lated with 5 mM cocaine for 1 h or 6 h (as indicated in each
experiment) in petri plates. DNA and proteins were cross-linked
with 0.5% formaldehyde followed by cell lysis in the buffer
previously described. The remaining nuclei were lysed with 1%
SDS buffer (supplemented with 10 mM EDTA, 50 mM Tris HCl,
1 mM EDTA, 1 mM DTT, 1 mM PMSF and a protease inhibitor
cocktail). For each immunoprecipitation reaction nuclear extract
of 5 to 8 million cells was used. The immunoprecipitation was
performed with antibodies speciﬁc to transcription factors
required for HIV transcription including RNAPII (Cat. no.: SC-
9001, Santa Cruz Biotech), HDAC3 (Cat. no.: SC-11417, Santa Cruz
Biotech), p-p65 (Ser 276) (Cat. no.: SC-101749, Santa Cruz Biotech),
p-MSK1 (Thr 581) (Cat. no.: 9595, Cell Signaling), P300 (Cat. no.:
SC-584, Santa Cruz Biotech), c-Jun (Cat. no.: SC-1694, Santa Cruz
Biotech), Cyclin T1 (Cat. no.: SC-8127, Santa cruz Biotech). The
chromatin structure at HIV-1 LTR was analyzed by utilizing
antibodies speciﬁc to selective epigenetic modiﬁcations such as,
Ac-H3 (Cat. no.: 07-352, Millipore), H3K9me3 (Cat. no.: 07-442,
Millipore), H3K27me3 (Cat. no.: 07-449, Millipore), H4K12-Ac (Cat.
no.: 04119, Millipore) and phospho-Histone-H3-Serine10 (Cat. no.:
12201, Cell signaling). The samples were then reverse cross-linked
and the immunoprecipitated DNA was analyzed by q-RT-PCR.
Quantitative real time PCR
Each ChIP DNA sample was analyzed by quantitative real-time PCR
to determine the amount of sample immunoprecipitated by the
antibody sets. Primers sets to the promoter region 116 to þ4 (50-
AGCTTGCTACAAGGGACTTTCC-30 and 50-ACCCAGTACAGGCAAAAAG-
CAG-30), and to the nucleosome 1 region þ30 to þ134 (50-CTGG-
GAGCTCTCTGGCTAACTA-30 and 50-TTACCAGAGTCACACAACAGACG-30)
were used to examine the proviral genome. The quantitative data
analysis was normalized with the appropriate IgG control and GAPDH.
Luciferase assay
2106 THP-1-pHR0-P-Luc-IRES-GFP cells were plated in 12-
well plates with RPMI supplemented with 10% FBS, penicillin and
streptavidin. The cells were incubated with 5 mM cocaine for 48 h
prior to harvesting and washed twice with PBS. Luciferase levels in
the cells were assessed using a Luciferase Assay System kit
(Promega). Brieﬂy, the cells were lysed for 30 min at room
temperature with passive lysis buffer and centrifuged at
14,000 rpm for 2 min. 10 mL of each sample was added to indivi-
dual wells, followed by 50 mL of luciferase substrate/assay buffer.
Each sample was tested in triplicate. Luminescence was read in a
Veritas Microplate Luminometer (Turner Biosystems).
Flow cytometry (FACs) analysis
FACS analyses were performed on cells infected with VSV-G
pseudotyped HIV-1 virus carrying the GFP gene under control of
the HIV-1 LTR promoter. The analyses were done with a FACS
Calibur (BD Biosciences), using FlowJo software (Treestar Inc.) to
collect and analyze the data.
Statistical analysis
All analyses were performed using GraphPad Prism software.
Data were analyzed by T test or One-way Anova. Data were
expressed as means7SEM and a p-value o0.05 was considered
statistically signiﬁcant.
Conclusions
Cocaine promotes HIV replication by enhancing both initiation
and elongation phases of HIV transcription by activating NF-ĸB
and MSK1.
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